statins
Women who take statins could be less likely to develop ovarian cancer, study finds
February 19, 2020Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins
A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …
Half of patients have sub-optimal response to statins, research shows
April 16, 2019Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins
Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …
New class of drugs offer alternative to statins
March 14, 2019Research and Development cholesterol, health, imperial college london, research, statins
A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study …
Research may unlock statins cancer-fighting ability
July 17, 2017Research and Development, Sales and Marketing Keele University, biotech, drugs, pharma, pharmaceutical, statins
Many previous studies have shown that statins are able to have an impact on cancer cells but the results have …
£6 million statin study to determine potential therapeutic use in MS
May 9, 2017Manufacturing and Production, Research and Development multiple sclerosis, statins
A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …
Statins revealed to potentially aid cancer treatment
January 25, 2017Research and Development Cancer, University of Kansan, statins
New research, conducted at the University of Kansas, has emerged that reveal a potential use for statins beyond their current …
Amgen’s high cholesterol drug at centre of patent court case yields positive clinical trial results
April 4, 2016Research and Development, Sales and Marketing Amgen, Repatha, Sanofi, high cholesterol. ldl, ldl-c, phase III, statins
Amgen has announced positive results from the Phase III GAUSS-3 clinical trial evaluating Repatha (evolucumab) in patients with high cholesterol …
Sanofi and Regeneron post positive alirocumab results
January 9, 2015Sales and Marketing Regeneron, Sanofi, cholesterol, heart, statin, statins
The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …
UK doctors are ignoring statin guidance
November 3, 2014Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins
A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …
Amgen submits next gen cholesterol drug
August 29, 2014Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins
Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …
Researchers question ‘bias’ NICE on statins
June 11, 2014Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins
Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …
NICE: ‘Use more statins’
February 12, 2014Sales and Marketing NHS, NICE, baker, cvd, statins
NICE has decided more NHS patients ought to be considered at risk of cardiovascular disease (CVD) – and therefore advises …
Latest content
FibroFind appoints Lee Borthwick as CEO
